Several reports have proposed the hypothesis that synovial fibroblasts play a major role in the crippling destruction of cartilage and bone in the inflamed joints of patients with rheumatoid arthritis (RA),la either autonomouslyl or in concert with T cells and macrophages. 1-3 4a 5 RA synovial fibroblasts are a major component of the invasive pannus,3 a vascular and fibrous granulation tissue arising from the joint recessus and extending onto the surface of the cartilage.6 A number of studies indicate that these fibroblasts are morphologically altered'-4 7 and, in addition, highly activated' 2 4a 8 9-phenotypic features that have been interpreted either as signs of irreversible cellular transformationl-4 7 or as the result of strong, but reversible stimulation originating from the surrounding inflammatory microenvironment.2 4a 5 Activation of fibroblasts in vitro is known to generate several functional responses, such as production of matrix components,'0 soluble mediators,"1 or enzymes' 2 4 8 11 that could contribute significantly to joint pathology in chronic RA in vivo. [1] [2] [3] [4] The present paper discusses the in situ characteristics and functional properties of activated RA synovial fibroblasts in relationship to the possible mechanisms of their alteration, and to their potential role(s) in the pathogenesis of the disease.
The in situ phenotype of RA synovial fibroblasts Morphological analysis of the RA synovium has demonstrated that fibroblasts in the lining layer have abundant cytoplasm and a large, pale nucleus with multiple prominent nucleoli, reminiscent of some tumours.7
Several studies have indicated that RA synovial fibroblasts express proto-oncogenes and other transcription factors, such as c-fos, jun-B, myc/c-myc, myb, ras, and the zinc factor Z-225/egr-1.1 2 4 4a 8 9 These different 'immediate-early response' genes are rapidly but transiently induced by a variety of activating stimuli,'6 " and can be regarded as markers of cell activation, regardless of whether the final outcome is proliferation, transformation, or secretion of cellular products. 17 Protein, mRNA, or both, of the protooncogenes c-fos, jun-B, and c-myc are massively expressed in both lining layer and diffuse infiltrates of the RA synovial membrane,18 closely matching the distribution of macrophages in these regions;'9 interestingly, there is a clear gradient of expression from the surface to the stroma of the synovial membrane, with the latter showing sparse and weak staining.4a
The nature of the cells positive for the protooncogenes c-fos, jun-B, and c-myc has been identified both by exclusion, as they do not express markers for macrophages (CD14, CD68) or for T cells (CD3),4a 18 and by positive characterisation through parallel, massive expression of mRNA for a2 (I) and o1 (III) collagens,4a or procollagen I protein. 18 These findings indicate that fibroblasts are virtually the only cell type within the RA synovial membrane to undergo massive activation, although a lesser degree of activation of T cells and macrophages cannot be excluded because of limitations in the sensitivity of the technique used. More importantly, the high expression of proto-oncogenes in RA synovial fibroblasts supports the hypothesis that these cells may not be in their normal, baseline functional status, but undergo pathological stimulation, either paracrine or autocrine.
We found that the proto-oncogenes c-fos and jun-B are also expressed in a small number of fibroblasts in normal synovial membrane, randomly distributed within the synovium,4a
conceivably reflecting baseline stimulation linked to normal functioning of the joint. In addition, proto-oncogenes are found in synovial fibroblasts of the osteoarthritis synovial membrane; as in RA, they are mostly expressed in areas with inflammatory infiltration, although the absolute number of positive cells is considerably smaller.4a
Proliferation and programmed celi death of synovial fibroblasts There have been several attempts to assess the proliferation rate of RA synovial cells, in particular fibroblasts, using 3H-thymidine incorporation or immunohistochemical detection of proliferation-specific markers. 18 20-23 Most of the studies agree that the proliferation rate in RA synovial membrane is less than 5/o20-23 a modest figure that could nevertheless be compatible with gradual expansion of fibroblasts during the course of chronic RA. A study on the expression of the proto-oncogene c-myc, the proliferating cell nuclear antigen, and the nucleolar organiser regions, ' however, appears to be counteracted by overexpression on RA synovial fluid cells of the Apo-1/Fas antigen, which can promote programmed cell death. 26 On the basis of the above findings it is possible that disruption of the delicate balance between cell proliferation, however low, and cell death contributes to synovial hyperplasia.
Contribution of synovial fibroblasts to joint pathology HUMAN RA Several proteolytic enzymes of the metallo-, cysteine, and serine protease classes have been implicated in the destruction of cartilage in the RA inflamed joint,27 and identified in situ in the lining layer' 4 12-15 [28] [29] [30] [31] 
Conclusions
Altered cellular morphology and massive expression of proto-oncogenes by fibroblast like cells in the hyperplastic RA synovial membrane have been regarded as an indication for a tumour like transformation of these cells.1-4 7-9 However, reversible morphological changes of fibroblasts, which may represent the counterpart of those observed in situ in the RA synovial membrane, have also been observed in vitro, both upon activation with inflammatory mediators47 and after transfection with the c-fos proto-oncogene.48 Moreover, protooncogenes do not unequivocally characterise tumoural cells, as they are non-specific signalling molecules common to a variety of (patho)physiological processes in the cell,'7 as demonstrated in this particular case by their expression in normal synovial membrane and in osteoarthritis,4a an unquestionably nontumoural joint alteration. More importantly, the in situ expression ofproto-oncogenes in RA synovial fibroblasts does not appear to reflect cell proliferation,4a thereby rendering unlikely the hypothesis of a tumour like transformation, at least in the sense of a highly proliferative malignant neoplasm.
Activated fibroblasts in the RA synovial membrane have a rather close spatial relationship with surrounding inflammatory cells and their mediators, especially macrophages, as they are distributed in a gradient fashion from the lining layer to the stroma.4a This observation supports the hypothesis that the activation of fibroblasts may result from reversible but sustained paracrine stimulation originating from the neighbouring inflammatory milieu.34 49 50 Potential mediators for such 'cross talk', such as IL-1, TNFa, and PDGF, are in turn abundantly and most closely available in the lining layer, or in the synovial fluid of RA joints. [35] [36] [37] [38] The induction of cartilage erosion by grafting of RA synovial tissue or fibroblasts in SCID mice4214 indicates that these cells may play a primary, potentially exclusive role in the development of arthritis. Therefore, it cannot be excluded that limited molecular transformation of the fibroblasts, reflected by massive expression of proto-oncogenes, is transferred to the host and consecutively maintained by reciprocal cooperation with host inflammatory cells. 45 46 Future studies should clarify whether the activation of RA synovial fibroblasts is an irreversible or reversible feature, addressing the question whether these cells are 'initiators' or 'perpetuators'3 of the RA disorder. 
